Triple Negative Breast Cancer makes the front page in the Austin-American Statesman

Great news from our local network of doctors.

Austin American Statesman article

"This is the most compelling development in breast cancer in the last five years," she said. "I had a patient come here from Puerto Rico to get access to this trial."


"Breast cancer experts not connected to the study greeted the results with excitement mixed with caution. For a cancer that is difficult to treat, iniparib shows great potential — provided the results are confirmed by the final, phase 3 trial, they said. Patients are still in that trial, and results will be out later this year, Patt said.